BGIM
ACER

Brandywine Global Investment Management’s Acer Therapeutics Inc ACER Stock Holding History

Brandywine Global Investment Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,100
Closed -$149K – 900
2019
Q1 		$149K Buy
+6,100
New +$144K ﹤0.01% 654

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Brandywine Global Investment Management's ACER Position: Q2 2019 in Review

Brandywine Global Investment Management sold out of Acer Therapeutics Inc (ACER) in Q2 2019, closing a stake of 6,100 shares — an estimated $149K sold.

Brandywine Global Investment Management first reported a position in ACER in Q1 2019 and held it in 1 quarter. The position peaked at $149K in Q1 2019. 37 funds tracked by Wall St. Rank hold ACER as of Q2 2019.

  • Brandywine Global Investment Management reported no remaining Acer Therapeutics Inc position as of Q2 2019 after selling out during the quarter.
  • Brandywine Global Investment Management sold 6,100 Acer Therapeutics Inc shares in Q2 2019, an estimated $149K.
  • Brandywine Global Investment Management first reported a position in Acer Therapeutics Inc in Q1 2019 and held it in 1 quarter.
  • Brandywine Global Investment Management's Acer Therapeutics Inc position peaked at $149K in Q1 2019.
  • 37 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2019.

Based on Brandywine Global Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.